Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
TEK
iShares Technology Opportunities Active ETF
$30.73
-0.2%
$28.98
$19.03
$30.79
$25.81MN/A8,575 shs9,504 shs
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$7.30
+2.4%
$6.31
$1.87
$10.70
$638.83M-0.041.16 million shs799,423 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
TEK
iShares Technology Opportunities Active ETF
+0.98%+3.99%+5.02%+15.54%+3,077,999,900.00%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-1.38%-2.06%+1.13%+82.82%-20.38%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
TEK
iShares Technology Opportunities Active ETF
$30.73
-0.2%
$28.98
$19.03
$30.79
$25.81MN/A8,575 shs9,504 shs
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$7.30
+2.4%
$6.31
$1.87
$10.70
$638.83M-0.041.16 million shs799,423 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
TEK
iShares Technology Opportunities Active ETF
+0.98%+3.99%+5.02%+15.54%+3,077,999,900.00%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-1.38%-2.06%+1.13%+82.82%-20.38%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
TEK
iShares Technology Opportunities Active ETF
2.88
Moderate Buy$30.73N/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
2.60
Moderate Buy$15.61113.84% Upside

Current Analyst Ratings Breakdown

Latest TERN, TEK, JTWO, and VEN2 Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/4/2025
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$7.44
(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
TEK
iShares Technology Opportunities Active ETF
N/AN/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/AN/AN/AN/A$4.07 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
TEK
iShares Technology Opportunities Active ETF
N/AN/A43.98N/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-$88.85M-$1.04N/AN/AN/AN/A-27.35%-26.18%11/11/2025 (Estimated)

Latest TERN, TEK, JTWO, and VEN2 Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-$0.28-$0.26+$0.02-$0.26N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
TEK
iShares Technology Opportunities Active ETF
N/A0.03%N/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
TEK
iShares Technology Opportunities Active ETF
N/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/A
24.70
24.70

Institutional Ownership

CompanyInstitutional Ownership
TEK
iShares Technology Opportunities Active ETF
N/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
98.26%

Insider Ownership

CompanyInsider Ownership
TEK
iShares Technology Opportunities Active ETF
N/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
1.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
TEK
iShares Technology Opportunities Active ETF
N/A840,000N/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
4087.51 million86.20 millionNot Optionable

Recent News About These Companies

Doing good in people’s lives: Amy Burroughs discusses CML
Research Analysts Issue Forecasts for TERN Q3 Earnings
What is HC Wainwright's Forecast for TERN Q3 Earnings?
Terns Pharmaceuticals, Inc. (TERN) Special Call - Slideshow

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

iShares Technology Opportunities Active ETF NYSEARCA:TEK

$30.73 -0.05 (-0.16%)
Closing price 04:10 PM Eastern
Extended Trading
$30.74 +0.00 (+0.02%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The iShares Technology Opportunities Active ETF (TEK) is an exchange-traded fund that mostly invests in information technology equity. The fund is actively managed, investing in US and non-US technology companies across all market capitalizations. The fund aims for long-term growth of capital, focusing on firms with rapid growth potential in the industry TEK was launched on Oct 21, 2024 and is issued by BlackRock.

Terns Pharmaceuticals stock logo

Terns Pharmaceuticals NASDAQ:TERN

$7.30 +0.17 (+2.38%)
Closing price 04:00 PM Eastern
Extended Trading
$7.39 +0.09 (+1.23%)
As of 06:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.